Doyle John Brendan has filed 13 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 1560 shares of COGNITION THERAPEUTICS INC ($CGTX) on February 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 1560 | $1.12 | 617,509.0000 | 77,951,513 | 0.25% | 0.00% |
| Feb. 4, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 26921 | $1.03 | 619,069.0000 | 77,951,513 | 4.17% | 0.03% |
| Feb. 3, 2026 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 200000 | $0.00 | 645,990.0000 | 77,951,513 | 44.84% | 0.26% |
| Dec. 18, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 9360 | $1.50 | 445,990.0000 | 77,951,513 | 2.06% | 0.01% |
| Dec. 18, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 455,350.0000 | 77,951,513 | 7.05% | 0.04% |
| July 29, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 434,710.0000 | 63,690,945 | 7.41% | 0.05% |
| July 29, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 9360 | $0.67 | 425,350.0000 | 63,690,945 | 2.15% | 0.01% |
| May 1, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 9692 | $0.45 | 404,710.0000 | 61,828,149 | 2.34% | 0.02% |
| Feb. 15, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 1723 | $0.59 | 414,402.0000 | 39,730,148 | 0.41% | 0.00% |
| Feb. 4, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 295000 | $0.00 | 416,125.0000 | 39,730,148 | 243.55% | 0.74% |
| May 1, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 8699 | $1.95 | 121,125.0000 | 33,735,269 | 6.70% | 0.03% |
| Feb. 15, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 30,029,087 | 9999.99% | 0.07% |
| Feb. 15, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 20000 | $0.00 | 129,824.0000 | 30,029,087 | 18.21% | 0.07% |